Analyst Report: COHR
1. EXECUTIVE SUMMARY
Coherent closed at $231.80 on Tuesday October 20, down 20.06% from $289.98 on October 13, in a selloff that hit optical and AI connectivity names together. The research brief found no company-specific negative news in the window. Coverage from 24/7 Wall St. tied the decline to doubts about how AI infrastructure is financed, set off by comments from Broadcom CEO Hock Tan and Intel CEO Lip-Bu Tan, and to rotation into defensives. The largest single-day drop came on October 14 (-9.19%), and the stock has been flat for the last two sessions (-0.38% and -0.09%). The October 16 session (-7.06%) has no confirmed cause. Management says fiscal 2027 is essentially fully booked, while free cash flow remains negative. Fiscal Q1 results on November 4 are the next test.
2. THE CATALYST
The selling began on October 12 (-7.87%), after a -9.63% session on October 8 that TIKR linked to rising Treasury yields and Fed rate-hike signals, again without company news. The window opened with a +0.68% session on October 13, then accelerated.
| Session | Close | Change | Driver per brief |
|---|---|---|---|
| Oct 14 | $263.32 | -9.19% | Sector trigger: capital access and borrowing cost comments |
| Oct 15 | $250.60 | -4.83% | Continued sector slide, rotation into defensives |
| Oct 16 | $232.90 | -7.06% | No confirmed cause |
| Oct 19 | $232.02 | -0.38% | Stabilisation |
| Oct 20 | $231.80 | -0.09% | Flat |
On October 14, 24/7 Wall St. reported that Hock Tan said access to capital could constrain AI expansion more than chip supply, and that Lip-Bu Tan pointed to higher borrowing costs and uncertainty about AI returns. The same source said the Roundhill Photonics & Optics ETF fell about 8% that day. Coherent also announced its earnings date on October 14 (Coherent via GlobeNewswire), which Quiverquant called a routine administrative update.
For October 15, 24/7 Wall St. described a stock dropping on sector moves rather than news, and Quiverquant cited sector repricing, risk-off trading in AI names and profit-taking after a strong run, with no adverse SEC filing. One 24/7 Wall St. article linked the session to a hot inflation report and a 30-year Treasury yield near 5.63%; that claim has a single source and is unconfirmed. For October 16, Quiverquant found no company-specific setback and pointed to weakness across AI optical and networking names. Attributing that session to sector weakness is inference from peer moves.
The brief also notes intraday figures in several articles that differ from the official closes; this report uses the closes.
3. COMPANY PROFILE
Coherent develops and sells lasers, transceivers and other optical and optoelectronic devices, modules and systems. Its Datacenter and Communications segment offers transceivers, co-packaged optics and optical circuit switches. It sits in the Technology sector. Peers in electronic components include Corning (GLW) and Amphenol (APH). Lumentum and Applied Optoelectronics trade alongside it as optical names.
Current-quarter guidance is revenue of $2.20bn to $2.40bn and EPS of $1.85 to $2.05 (24/7 Wall St.). The site's consensus for the November 4 report is EPS of 1.96 on revenue of $2.30bn, near the midpoint of guidance. The CEO said fiscal 2027 is essentially fully booked, with orders extending into calendar 2028 and long-term agreements running to the end of the decade, and that Coherent expects quarterly revenue above $3 billion by the end of fiscal 2027 (24/7 Wall St.). Analysts cite indium phosphide output doubling this quarter, co-packaged optics revenue beginning to ramp in fiscal Q2, and a gross margin target above 42%.
The balance sheet carries strain. TIKR reports fiscal 2026 free cash flow of about negative $1.02bn and net debt of about $2.06bn, or 1.21x EBITDA. 24/7 Wall St. adds capex of $1.103bn against operating cash flow of $79.5m.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The brief offers no evidence of a change in orders, guidance or filings. The decline therefore looks like a repricing of AI-linked risk, with funding costs as the stated worry. The cash flow picture gives that worry a company-level anchor: heavy capex and negative free cash flow leave Coherent more exposed to financing conditions than its order book suggests. That link is inference. The forward P/E of 16.5 against a trailing 56.3 shows the market is pricing a steep earnings increase, which makes the shares sensitive to doubts about delivery.
Peers. Over the same period Corning fell 10.96% and Amphenol 7.65%, against -1.19% for the S&P 500. Coherent's -20.06% is roughly double the peer moves, which fits a high-beta AI optics holding. Lumentum and Coherent were the two largest holdings of the photonics ETF as of August 6 (24/7 Wall St.).
Comparable episodes. Coherent fell about 9.6% on October 8 with no company news (TIKR). In early July it fell nearly 10% in a session despite a Raymond James target increase, which TIKR called profit-taking (exact date not stated). 24/7 Wall St. also cites a $2bn at-the-market offering by a fiber maker that dragged Coherent about 11% lower in sympathy, with no date given. These episodes show that sector selloffs have repeatedly produced sharp single-session drops in this stock.
Analyst actions. B. Riley's Dave Kang cut his target to $297 from $345 with a Hold rating on October 15 (TipRanks). Rosenblatt's Mike Genovese reiterated Buy on October 13 with an unchanged $500 target, the highest on the Street (TradingView, GuruFocus). Bernstein's Daniel Zhu was reported at a $350 target on October 12 (TipRanks); the rating label conflicts between sources and is unconfirmed. Argus raised its target to $406 on October 7. MarketBeat counts 15 open-market insider sales and no purchases over six months, and states this does not establish a cause for the decline.
Bull case. Booked capacity through fiscal 2027, long-term agreements, a product ramp in co-packaged optics and indium phosphide, and guidance that consensus sits within. At $231.80 the stock is well below every target cited above.
Bear case. Negative free cash flow, rising borrowing costs, insider selling, and a stock that has fallen sharply with no sign yet that selling pressure has ended.
5. TECHNICAL SNAPSHOT
The close of $231.80 sits below the 50-day average of $295.04 and the 200-day average of $294.93, which are almost identical, and is the lowest close in the ten-session table. No lower close in the table provides a support level. The stock is 47.3% below the 52-week high of $440.00 set on June 3 and well above the 52-week low of $112.96. Last session volume of 6,146,100 was 0.87x the 50-day average of 7,037,264, so the flat closes of the past two sessions came on lighter trading. The heaviest volume in the table, 9,951,200, came on October 15, with 9,285,100 on October 8.
6. RISK FACTORS
- Funding sentiment: further comments on AI financing or rising yields could extend the sector decline.
- Earnings: fiscal Q1 2027 results are due November 4 after the NYSE close, with a 4:30 p.m. ET webcast. The site's estimates are EPS of 1.96 and revenue of $2.30bn.
- Cash flow: capex is far above operating cash flow, and net debt stands at about $2.06bn.
- Unread items: the brief did not open a October 20 Investing.com piece on the slide or a Bernstein earnings preview from the same day, either of which may add information on the latest sessions.
- Earnings season read-across: reports from optical peers will move the group before Coherent reports.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): The stock has held between $231.80 and $232.90 for three closes on declining volume, which is a pause after a $58 fall over the week. Direction depends on sector sentiment toward AI financing and on peer earnings. A renewed rise in yields would pressure the group, while steadier risk appetite would let the shares recover part of the loss.
Medium term (1-3 months): The November 4 report decides the path. Results in line with the $2.20bn to $2.40bn guidance range and confirmation of the booking commentary would support the bull case, while weak cash generation or a cautious margin outlook would reinforce the bear case.
Long term: The brief contains no evidence that the demand thesis has changed. The financing and cash flow questions have become more prominent, and they are the points to monitor. This is analysis only and not personal financial advice.